MALAT1 Up-Regulator Polydatin Protects Brain Microvascular Integrity and Ameliorates Stroke Through C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ Pathway

• DOI: 10.1007/s10571-018-00646-4
• Publication Date: 2019-01-03T11:49:46Z
• Authors: Wenchen Ruan; Jingwei Li; Yazhou Xu; Yunjie Wang; Feng Zhao; Xu Yang; Hulin Jiang; Luyong Zhang; Juan M. Saavedra; Lei Shi; Tao Pang
• Keywords: 0303 health sciences; Time Factors; Base Sequence; CCAAT-Enhancer-Binding Protein-beta; Brain; Infarction, Middle Cerebral Artery; Models, Biological; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; 3. Good health; PPAR gamma; Rats, Sprague-Dawley; Stroke; 03 medical and health sciences; HEK293 Cells; Glucosides; Blood-Brain Barrier; Microvessels; Stilbenes; Human Umbilical Vein Endothelial Cells; Animals; Humans; RNA, Long Noncoding; Cyclic AMP Response Element-Binding Protein

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA contributing to protect the blood-brain barrier (BBB) after stroke. We searched for small molecules that may up-regulate MALAT1 and focused on polydatin (PD), a natural product, as a possible candidate. PD enhanced MALAT1 gene expression in rat brain microvascular endothelial cells, reducing cell toxicity and apoptosis after oxygen and glucose deprivation (OGD). These effects correlated with reduction of inflammatory factors and enhancement of expression of BBB markers. We found opposite changes after MALAT1 silencing. We determined that C/EBPβ is a key transcription factor for PD-mediated MALAT1 expression. PPARγ activity is involved in MALAT1 protective effects through its coactivator PGC-1α and the transcription factor CREB. This suggests that PD activates the MALAT1/CREB/PGC-1α/PPARγ signaling pathway to protect endothelial cells against ischemia. PD administration to rats subjected to brain ischemia by transient middle cerebral artery occlusion (tMCAO) reduced cerebral infarct volume and brain inflammation, protected cerebrovascular endothelial cells and BBB integrity. These effects correlated with increased expression of MALAT1, C/EBPβ, and PGC-1α. Our results strongly suggest that the beneficial effects of PD involve the C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ pathway, which may provide a novel therapeutic strategy for brain ischemic stroke.